000 01098 a2200289 4500
005 20250517165722.0
264 0 _c20180515
008 201805s 0 0 eng d
022 _a1096-1186
024 7 _a10.1016/j.phrs.2017.07.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaurent, Stéphane
245 0 0 _aAntihypertensive drugs.
_h[electronic resource]
260 _bPharmacological research
_cOct 2017
300 _a116-125 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic beta-Antagonists
_xadverse effects
650 0 4 _aAngiotensin Receptor Antagonists
_xadverse effects
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xadverse effects
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aCalcium Channel Blockers
_xadverse effects
650 0 4 _aDiuretics
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
773 0 _tPharmacological research
_gvol. 124
_gp. 116-125
856 4 0 _uhttps://doi.org/10.1016/j.phrs.2017.07.026
_zAvailable from publisher's website
999 _c27438356
_d27438356